Publication Beamlines Strategic Pillar
Bauer, Robert P. C.; Rodriguez, Danny; Pathak, Santanu; Tse, John S. (2025). Capturing Hydrate Formation Processes in Tetrahydrofuran/Water Mixtures with Temperature Resolved In Situ Synchrotron X-ray Diffraction and Infrared Spectroscopy. Journal of Physical Chemistry Letters , 5160-5167. 10.1021/acs.jpclett.5c00576. BXDS-WHE, FAR-IR, HXMA Environment
Zhang, Hanyu; Xia, Liuyin; Zhu, Ning; Gasilov, Sergey; He, Iris et al. (2025). Synchrotron X-ray imaging study on the mechanism of solids transfer to bitumen froth during oil sands flotation 1: True flotation. Cleaner Engineering and Technology 25, 100894. 10.1016/j.clet.2025.100894. BMIT-ID Environment
Tunc, Ayetullah; Lin, Jinru; Pan, Yuanming; Chen, Ning; Feng, Renfei et al. (2025). Proof of Uranyl Deposition in Unconformity-Related Uranium Deposits, Athabasca Basin, Canada: Evidence from Synchrotron XAS and XPS Analyses of Hematite. Canadian Journal of Mineralogy and Petrology 63(1) , 3-26. 10.3749/2400013. BIOXAS, HXMA, SXRMB, VESPERS Environment
Mundboth, Kiran (2025). Canadian Light Source – 20 Years of Discovery. Canadian Journal of Chemistry . 10.1139/cjc-2024-0278. BMIT, BXDS, CMCF, FAR-IR, HXMA, MID-IR, SM Health
Mundboth, Kiran (2025). Canadian Light Source – 20 Years of Discovery. Canadian Journal of Chemistry . 10.1139/cjc-2024-0278. BMIT, BXDS, CMCF, FAR-IR, HXMA, MID-IR, SM Health
Mundboth, Kiran (2025). Canadian Light Source – 20 Years of Discovery. Canadian Journal of Chemistry . 10.1139/cjc-2024-0278. BMIT, BXDS, CMCF, FAR-IR, HXMA, MID-IR, SM Health
Mundboth, Kiran (2025). Canadian Light Source – 20 Years of Discovery. Canadian Journal of Chemistry . 10.1139/cjc-2024-0278. BMIT, BXDS, CMCF, FAR-IR, HXMA, MID-IR, SM Health
Vallée, Frédéric; Casás-Selves, Matias; Bubenik, Monica; Duplessis, Martin; Sow, Boubacar et al. (2025). Discovery of RP-1664: A First-in-Class Orally Bioavailable, Selective PLK4 Inhibitor. Journal of Medicinal Chemistry . 10.1021/acs.jmedchem.5c00529. [PDB: 9o63] CMCF-ID Health
Ye, Qilu; Eves, Robert; Vance, Tyler D. R.; Hansen, Thomas; Sage, Adam P. et al. (2025). Aeromonas hydrophila RTX adhesin has three ligand-binding domains that give the bacterium the potential to adhere to and aggregate a wide variety of cell types. mBio 16(5) . 10.1128/mbio.03158-24. [PDB: 9cse] CMCF-ID Health
Kinzel, Olaf; Goldberg, Steven D.; Cummings, Maxwell D.; Gege, Christian; Steeneck, Christoph et al. (2025). Identification of JNJ-61803534, a RORγt Inverse Agonist for the Treatment of Psoriasis. Journal of Medicinal Chemistry 68(8) , 8713-8728. 10.1021/acs.jmedchem.5c00390. [PDB: 9n9l] CMCF-ID Health
Goncalves, Monica M.; Uday, Adwaith B.; Forrester, Taylor J. B.; Currie, S. Quinn W.; Kim, Angelina S. et al. (2025). Mechanism of allosteric activation in human mitochondrial ClpP protease. Proceedings of the National Academy of Sciences of the United States of America 122(16) . 10.1073/pnas.2419881122. [PDB: 9dqk, 9dql] CMCF-ID Health
Nakhla, Mina C.; Comita, Janelle; Shapiro, Adam B.; Moussa, Samir H.; Chen, April et al. (2025). Small molecule inhibitors of mannan-binding lectin-associated serine Proteases-2 and-3. European Journal of Medicinal Chemistry 289, 117238. 10.1016/j.ejmech.2025.117238. [PDB: 9d17, 9d3y, 9d40, 9d4d] CMCF-ID Health
Walker, Morgan E.; Zhu, Wei; Peterson, Janine H.; Wang, Hao; Patteson, Jon et al. (2025). Antibacterial macrocyclic peptides reveal a distinct mode of BamA inhibition. Nature Communications 16(1) . 10.1038/s41467-025-58086-w. [PDB: 9cs0, 9cs1] CMCF-ID Health
Cregg, James; Edwards, Anne V.; Chang, Stephanie; Lee, Bianca J.; Knox, John E. et al. (2025). Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers. Journal of Medicinal Chemistry . 10.1021/acs.jmedchem.4c02314. [PDB: 9bg0, 9bg2, 9bg3, 9bg4, 9bg5, 9bg6, 9bg8, 9bga, 9bgb, 9bgc, 9bgd] CMCF-ID Health
Cregg, James; Pota, Kristof; Tomlinson, Aidan C. A.; Yano, Jason; Marquez, Abby et al. (2025). Discovery of Elironrasib (RMC-6291), a Potent and Orally Bioavailable, RAS(ON) G12C-Selective, Covalent Tricomplex Inhibitor for the Treatment of Patients with RAS G12C-Addicted Cancers. Journal of Medicinal Chemistry . 10.1021/acs.jmedchem.4c02313. [PDB: 9bfv, 9bfw] CMCF-ID Health